/
Other
CAR
37
Pipeline Programs↗
36
Active Trials↗
48
Companies Involved↗
CAR is a moderately active landscape with 37 programs across 48 companies. The most active players are Novartis, Pfizer, SpringWorks Therapeutics, Inc.. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical19
Phase 19
Phase 24
Phase 35
Approved
No programs
Analysis
Modality Breakdown
92%
Small molecule
24 of 26 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 26 classified programs, each share of the total. Modality classified for 100% of 37 pipeline programs.
Analysis
Trial Status
311
clinical trials
Completed205 · 66%
Unknown status33 · 11%
Terminated23 · 7%
Recruiting21 · 7%
Withdrawn10 · 3%
Not yet recruiting6 · 2%
Other13 · 4%
Clinical Trials
Trial Activity
311 trials
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Recruiting·CCenters for Medicare and Medicaid Services/ Coverage and Analysis Group·N/A·NCT06058234·8,680 enrolled
Page 1 of 21
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)